As RAD54L2-mediated TOP2cc resolution could represent a mechanism for intrinsic or acquired tumor resistance to chemotherapies including TOP2 poisons, it represents a potential biomarker and a candidate target for anticancer drug discovery. The gene discussed is RAD54L2; the disease is neoplasm.